A Review Of Cancer Immunotherapy Toxicity

CA
03 Jul, 2020 ,

Lucy Boyce Kennedy et.al. conducted a study to focus on the toxicities of checkpoint inhibitors and chimeric antigen receptor T cells, including pathophysiology, diagnosis, and management. The researchers concluded that cornerstone of toxicity management is often steroids or immunosuppression, and ongoing studies are evaluating the effect of immunosuppression on antitumor efficacy.

Source